427 related articles for article (PubMed ID: 29953622)
1. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
von Achenbach C; Weller M; Szabo E
J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
[TBL] [Abstract][Full Text] [Related]
2. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
3. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
[TBL] [Abstract][Full Text] [Related]
4. Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells.
Erjala K; Sundvall M; Junttila TT; Zhang N; Savisalo M; Mali P; Kulmala J; Pulkkinen J; Grenman R; Elenius K
Clin Cancer Res; 2006 Jul; 12(13):4103-11. PubMed ID: 16818711
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.
Wu W; O'Reilly MS; Langley RR; Tsan RZ; Baker CH; Bekele N; Tang XM; Onn A; Fidler IJ; Herbst RS
Mol Cancer Ther; 2007 Oct; 6(10):2652-63. PubMed ID: 17913856
[TBL] [Abstract][Full Text] [Related]
6. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
8. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
9. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
[TBL] [Abstract][Full Text] [Related]
10. High epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.
Auf G; Jabouille A; Delugin M; Guérit S; Pineau R; North S; Platonova N; Maitre M; Favereaux A; Vajkoczy P; Seno M; Bikfalvi A; Minchenko D; Minchenko O; Moenner M
BMC Cancer; 2013 Dec; 13():597. PubMed ID: 24330607
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo.
Ezeh PI; Farbman AI
J Neurobiol; 1998 Nov; 37(2):199-210. PubMed ID: 9805267
[TBL] [Abstract][Full Text] [Related]
14. Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization.
Lenferink AE; Kramer RH; van Vugt MJ; Königswieser M; Di Fiore PP; van Zoelen EJ; van de Poll ML
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):859-65. PubMed ID: 9581567
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
Blandin AF; Cruz Da Silva E; Mercier MC; Glushonkov O; Didier P; Dedieu S; Schneider C; Devy J; Etienne-Selloum N; Dontenwill M; Choulier L; Lehmann M
Cell Mol Life Sci; 2021 Mar; 78(6):2949-2962. PubMed ID: 33151388
[TBL] [Abstract][Full Text] [Related]
17. Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand.
Ali R; Brown W; Purdy SC; Davisson VJ; Wendt MK
Cell Death Dis; 2018 Sep; 9(10):976. PubMed ID: 30250119
[TBL] [Abstract][Full Text] [Related]
18. Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells.
Thomas SM; Grandis JR; Wentzel AL; Gooding WE; Lui VW; Siegfried JM
Neoplasia; 2005 Apr; 7(4):426-31. PubMed ID: 15967120
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]